(Total Views: 457)
Posted On: 05/13/2020 10:37:56 AM
Post# of 154453
Funny, I'm having this problem too.
However, CytoDyn's clinical trial, FDA approval, and time-to-market timelines are allowing me to still analyze short and medium term opportunities.
But I do find myself thinking that some of these companies/drugs might be decimated by leronlimab.
However, CytoDyn's clinical trial, FDA approval, and time-to-market timelines are allowing me to still analyze short and medium term opportunities.
But I do find myself thinking that some of these companies/drugs might be decimated by leronlimab.
(1)
(0)
